Can a barley and kefir breakfast reshape the gut? trial puts it to the test

NCT ID NCT07864779

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 08, 2026 · Last updated Oct 09, 2026 · Updated 1 time

Summary

Researchers are testing whether eating a daily breakfast of barley porridge and kefir for four weeks changes the mix of bacteria in the gut. The trial enrolls 80 physically active adults aged 18 to 55 who do endurance sports. Half receive the breakfast, half keep their usual diet. Scientists compare stool, blood, and urine samples before and after to see how gut bacteria and related metabolites shift.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a daily breakfast of barley porridge and kefir
What this could lead to
If the diet changes gut bacteria, it could point to simple food-based ways to support gut health, recovery, and performance in active people.
What could go wrong
This is a small, four-week study in highly fit adults, so any changes may be modest and may not apply to other groups. Diet studies also struggle to prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Jun 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 - 55 years * High aerobic capacity defined by the following minimum estimated VO₂max values: Men: * 20-29 years: ≥ 51 mL/kg/min * 30-39 years: ≥ 47 mL/kg/min * 40-49 years: ≥ 43 mL/kg/min * 50-55 years: ≥ 38 mL/kg/min Women: * 20-29 years: ≥ 44 mL/kg/min * 30-39 years: ≥ 40 mL/kg/min * 40-49 years: ≥ 36 mL/kg/min * 50-55 years: ≥ 32 mL/kg/min Exclusion Criteria: * Pregnancy * Ulcerative colitis * Crohn's disease * Coeliac disease * Milk allergy * Lactose intolerance * Use of antibiotics within the previous 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gut microbiota diversity and composition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Western Norway University of Applied Sciences

    RECRUITING

    Bergen, 5225, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.